01 9Cosentyx
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 3,995
2019 Revenue in Millions : 3,551
Growth (%) : 13
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 4,718
2020 Revenue in Millions : 3,995
Growth (%) : 18
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 4,788
2021 Revenue in Millions : 4,718
Growth (%) : 1
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 4,980
2022 Revenue in Millions : 4,788
Growth (%) : 4
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 261
Growth (%) : New Launch
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2016 Revenue in Millions : 1,128
2015 Revenue in Millions : 261
Growth (%) : 332
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2017 Revenue in Millions : 2,071
2016 Revenue in Millions : 1,128
Growth (%) : 84
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2018 Revenue in Millions : 2,837
2017 Revenue in Millions : 2,071
Growth (%) : 37%
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 3,551
2018 Revenue in Millions : 2,837
Growth (%) : 25
LOOKING FOR A SUPPLIER?
